Key Financial Data Of Reporting Company

Medrx Co.,Ltd. - Filing #7312833

Concept 2024-01-01 to
2024-06-30
As at
2024-06-30
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
231,478,000 JPY
29,534,000 JPY
6,963,000 JPY
Ordinary profit (loss)
-84,950,000 JPY
-930,634,000 JPY
-480,591,000 JPY
Net assets
2,487,434,000 JPY
1,924,731,000 JPY
1,680,295,000 JPY
Total assets
2,532,764,000 JPY
2,052,252,000 JPY
1,736,748,000 JPY
Basic earnings (loss) per share
-1.51
-26.82
-14.97
Diluted earnings per share
Equity-to-asset ratio
0.962 xbrli:pure
0.906 xbrli:pure
0.930 xbrli:pure
Net cash provided by (used in) operating activities
-218,271,000 JPY
-913,800,000 JPY
-615,290,000 JPY
Net cash provided by (used in) investing activities
-265,000 JPY
-759,000 JPY
-239,000 JPY
Net cash provided by (used in) financing activities
658,944,000 JPY
1,639,492,000 JPY
950,272,000 JPY
Cash and cash equivalents
2,166,353,000 JPY
1,720,720,000 JPY
1,326,217,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.